SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction (Homo sapiens)
From WikiPathways
Description
Long COVID-19 (Coronavirus disease) ranges from lingering symptoms 6-12 months after contracting COVID-19 to severe implications caused by the virus. To understand the (molecular) mechanisms underlying Long COVID-19 and the potential role of chronic oxidative stress, this pathway concisely visualises mitochondrial hijacking by SARS-COV-2 leading to pro-senescent mitochondrial dysfunction and inflammation.
Quality Tags
Ontology Terms
Bibliography
View all... |
- Gatti P, Ilamathi HS, Todkar K, Germain M; ''Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2.''; Front Pharmacol, 2020 PubMed Europe PMC Scholia
- Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP; ''Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity.''; iScience, 2020 PubMed Europe PMC Scholia
- Kumar V; ''Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.''; Int Immunopharmacol, 2020 PubMed Europe PMC Scholia
- Brendan Miller, Ana Silverstein, Melanie Flores, Kevin Cao, Hiroshi Kumagai, Hemal H Mehta, Kelvin Yen, Su- Jeong Kim, Pinchas Cohen; ''Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples''; nature, 2021 PubMed Europe PMC Scholia
- Hemmat N, Asadzadeh Z, Ahangar NK, Alemohammad H, Najafzadeh B, Derakhshani A, Baghbanzadeh A, Baghi HB, Javadrashid D, Najafi S, Ar Gouilh M, Baradaran B; ''The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.''; Arch Virol, 2021 PubMed Europe PMC Scholia
- Chang R, Mamun A, Dominic A, Le NT; ''SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress.''; Front Physiol, 2020 PubMed Europe PMC Scholia
- Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O'Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA, Hüttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Meyer B, Roesch F, Vallet T, Mac Kain A, Miorin L, Moreno E, Naing ZZC, Zhou Y, Peng S, Shi Y, Zhang Z, Shen W, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Lyu J, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Rakesh R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Liboy-Lugo J, Lin Y, Huang XP, Liu Y, Wankowicz SA, Bohn M, Safari M, Ugur FS, Koh C, Savar NS, Tran QD, Shengjuler D, Fletcher SJ, O'Neal MC, Cai Y, Chang JCJ, Broadhurst DJ, Klippsten S, Sharp PP, Wenzell NA, Kuzuoglu-Ozturk D, Wang HY, Trenker R, Young JM, Cavero DA, Hiatt J, Roth TL, Rathore U, Subramanian A, Noack J, Hubert M, Stroud RM, Frankel AD, Rosenberg OS, Verba KA, Agard DA, Ott M, Emerman M, Jura N, von Zastrow M, Verdin E, Ashworth A, Schwartz O, d'Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor SN, Fraser JS, Gross JD, Sali A, Roth BL, Ruggero D, Taunton J, Kortemme T, Beltrao P, Vignuzzi M, García-Sastre A, Shokat KM, Shoichet BK, Krogan NJ.; ''A SARS-CoV-2 protein interaction map reveals targets for drug repurposing''; Nature , 2020 PubMed Europe PMC Scholia
- Kumar V; ''Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.''; Int Immunopharmacol, 2020 PubMed Europe PMC Scholia
- Sebastian Kreimendahl, Joachim Rassow; ''The Mitochondrial Outer Membrane Protein Tom70-Mediator in Protein Traffic, Membrane Contact Sites and Innate Immunity''; iscience, 2020 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Annotated Interactions
No annotated interactions